Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 231.0
(0.87%)
JPY 231.0
(0.87%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 108.95 Million JPY | -21.19% |
| 2022 | 138.25 Million JPY | -42.04% |
| 2021 | 238.54 Million JPY | 139.63% |
| 2020 | -601.85 Million JPY | 63.67% |
| 2019 | -1.65 Billion JPY | -813.8% |
| 2018 | -181.28 Million JPY | -243.92% |
| 2017 | 125.95 Million JPY | 32.94% |
| 2016 | 94.74 Million JPY | 361.9% |
| 2015 | 20.51 Million JPY | -75.39% |
| 2014 | 83.34 Million JPY | -90.13% |
| 2013 | 844.79 Million JPY | 360.77% |
| 2012 | 183.34 Million JPY | 182.52% |
| 2011 | -222.17 Million JPY | 47.79% |
| 2010 | -425.5 Million JPY | -977.0% |
| 2009 | 48.51 Million JPY | -86.19% |
| 2008 | 351.36 Million JPY | -13.65% |
| 2007 | 406.89 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -11.35 Million JPY | -140.79% |
| 2023 Q1 | 100.76 Million JPY | 262.11% |
| 2023 FY | 108.95 Million JPY | -21.19% |
| 2023 Q4 | 27.83 Million JPY | 61.2% |
| 2023 Q3 | 17.26 Million JPY | 105.34% |
| 2023 Q2 | -323.53 Million JPY | -421.06% |
| 2022 Q3 | 131.94 Million JPY | 892.67% |
| 2022 FY | 138.25 Million JPY | -42.04% |
| 2022 Q4 | 27.82 Million JPY | -78.91% |
| 2022 Q2 | -16.64 Million JPY | -241.53% |
| 2022 Q1 | -4.87 Million JPY | -117.23% |
| 2021 Q3 | 98.42 Million JPY | 46.53% |
| 2021 FY | 238.54 Million JPY | 139.63% |
| 2021 Q4 | 28.29 Million JPY | -71.26% |
| 2021 Q1 | 44.65 Million JPY | 198.26% |
| 2021 Q2 | 67.17 Million JPY | 50.41% |
| 2020 Q3 | 76.05 Million JPY | 111.42% |
| 2020 Q2 | -666.12 Million JPY | -2078.73% |
| 2020 Q1 | 33.66 Million JPY | 134.63% |
| 2020 Q4 | -45.45 Million JPY | -159.76% |
| 2020 FY | -601.85 Million JPY | 63.67% |
| 2019 Q1 | -289.77 Million JPY | 22.34% |
| 2019 FY | -1.65 Billion JPY | -813.8% |
| 2019 Q2 | -1.33 Billion JPY | -360.06% |
| 2019 Q3 | 63.55 Million JPY | 104.77% |
| 2019 Q4 | -97.2 Million JPY | -252.94% |
| 2018 Q4 | -373.12 Million JPY | -267.09% |
| 2018 FY | -181.28 Million JPY | -243.92% |
| 2018 Q1 | 100.46 Million JPY | -11.03% |
| 2018 Q3 | 223.31 Million JPY | 269.27% |
| 2018 Q2 | -131.92 Million JPY | -231.32% |
| 2017 Q4 | 112.91 Million JPY | 16.01% |
| 2017 Q2 | -183.82 Million JPY | -284.68% |
| 2017 FY | 125.95 Million JPY | 32.94% |
| 2017 Q1 | 99.53 Million JPY | 371.63% |
| 2017 Q3 | 97.33 Million JPY | 152.95% |
| 2016 FY | 94.74 Million JPY | 361.9% |
| 2016 Q1 | 85.42 Million JPY | 157.79% |
| 2016 Q3 | 107.29 Million JPY | 190.11% |
| 2016 Q2 | -119.07 Million JPY | -239.4% |
| 2016 Q4 | 21.1 Million JPY | -80.33% |
| 2015 Q3 | 106.69 Million JPY | 474.88% |
| 2015 Q4 | -147.81 Million JPY | -238.54% |
| 2015 FY | 20.51 Million JPY | -75.39% |
| 2015 Q1 | 90.09 Million JPY | 152.72% |
| 2015 Q2 | -28.46 Million JPY | -131.59% |
| 2014 Q4 | -170.88 Million JPY | -170.37% |
| 2014 FY | 83.34 Million JPY | -90.13% |
| 2014 Q3 | 242.84 Million JPY | 1173.01% |
| 2014 Q2 | -22.63 Million JPY | -166.53% |
| 2014 Q1 | 34.01 Million JPY | -94.35% |
| 2013 Q3 | 237.51 Million JPY | 888.47% |
| 2013 Q4 | 601.9 Million JPY | 153.42% |
| 2013 FY | 844.79 Million JPY | 360.77% |
| 2013 Q1 | 35.49 Million JPY | -85.27% |
| 2013 Q2 | -30.12 Million JPY | -184.86% |
| 2012 Q3 | 183.82 Million JPY | 208.0% |
| 2012 Q4 | 240.98 Million JPY | 31.1% |
| 2012 FY | 183.34 Million JPY | 182.52% |
| 2012 Q1 | -71.26 Million JPY | -235.9% |
| 2012 Q2 | -170.2 Million JPY | -138.82% |
| 2011 FY | -222.17 Million JPY | 47.79% |
| 2011 Q1 | -64.19 Million JPY | -1855.32% |
| 2011 Q2 | -56.97 Million JPY | 11.25% |
| 2011 Q3 | -79.78 Million JPY | -40.05% |
| 2011 Q4 | -21.21 Million JPY | 73.41% |
| 2010 FY | -425.5 Million JPY | -977.0% |
| 2010 Q2 | -239.44 Million JPY | -80.37% |
| 2010 Q1 | -132.75 Million JPY | -56.05% |
| 2010 Q3 | -50.02 Million JPY | 79.11% |
| 2010 Q4 | -3.28 Million JPY | 93.44% |
| 2009 Q4 | -85.07 Million JPY | -184.51% |
| 2009 Q1 | -63.67 Million JPY | 17.11% |
| 2009 FY | 48.51 Million JPY | -86.19% |
| 2009 Q2 | 96.6 Million JPY | 251.71% |
| 2009 Q3 | 100.66 Million JPY | 4.2% |
| 2008 Q4 | -76.82 Million JPY | -135.62% |
| 2008 Q3 | 215.7 Million JPY | 320.06% |
| 2008 Q2 | 51.35 Million JPY | 0.0% |
| 2008 FY | 351.36 Million JPY | -13.65% |
| 2007 FY | 406.89 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | 96.6% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 99.924% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 100.035% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 99.933% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 99.579% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 98.642% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 99.743% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | 84.367% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 99.22% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | 97.604% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | 92.087% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 160.533% |
| Tsumura & Co. | 16.7 Billion JPY | 99.348% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 99.024% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | 97.355% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 99.326% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | 96.828% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | 98.591% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | 97.953% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 102.226% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | 96.693% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 105.551% |
| MedRx Co., Ltd | -932 Million JPY | 111.691% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | 97.113% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 109.798% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 104.555% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | 98.556% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 99.204% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 118.492% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 99.473% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | 96.302% |